Pharmacology & Molecular Microbiology
- Number of publications
- 223
Publications
-
Sundaram V; Petkova MI; Pujol-Carrion N; Boada J; de la Torre-Ruiz MA
Tor1, Sch9 and PKA downregulation in quiescence rely on Mtl1 to preserve mitochondrial integrity and cell survival
MOLECULAR MICROBIOLOGY 97 93-109. .
-
G Cortés JC; Pujol N; Sato M; Pinar M; Ramos M; Moreno B; Osumi M; Ribas JC; Pérez P
Cooperation between Paxillin-like Protein Pxl1 and Glucan Synthase Bgs1 Is Essential for Actomyosin Ring Stability and Septum Formation in Fission Yeast
Plos Genetics 11 -. .
-
Muniesa Royo M; March de Ribot A; Sánchez-de-la-Torre M; Huerva Escanilla V; Jurjo Campo C; Barbé Illa F
Corneal Biomechanical Properties in Floppy Eyelid Syndrome
Cornea 34 521-524. .
-
Huerva V; Carmen Sanchez M; Jesus Muniesa M
ExPRESS Shunt Surgery for Glaucoma with Post-Traumatic Aniridia
Seminars in Ophthalmology 30 218-220. .
-
Huerva V; Sanchez MC
Infectious Crystalline Keratopathy Caused by Pseudomonas fluorescens
EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE 41 9-10. .
-
Borrás Pérez, V.; López-Siguero, J.P.; MartÃnez, G.; Corripio, R.; Fernández, J.M.; Labarta, J.I.; Ferrer, M.; Cabrinety, N.; Prieto, P.; Ramón-Krauel, M.; Bosch, J.; Espino, R.; Palla Garcia, M.; Rebollo, F.J.
A Follow-up Study to Monitor Adult Height Among Spanish Children with Growth Hormone Deficiency Who Received Biosimilar Human Recombinant Growth Hormone (Omnitrope(A (R))) During a Phase III Clinical Trial
Advances in Therapy 32 148-156. .
-
Huerva V; Ascaso FJ; Grzybowski A
Ocular Inflammation
Mediators of Inflammation 2015 398076-398076. .
-
Huerva V
Lichen planus on the ocular surface
Cutaneous And Ocular Toxicology 34 232-233. .
-
Ribas J; Mattiolo P; Boix J
Pharmacological Modulation of Reactive Oxygen Species in Cancer Treatment
CURRENT DRUG TARGETS 16 31-37. .
-
de la Torre-Ruiz MA; Pujol N; Sundaram V
Coping With Oxidative Stress. The Yeast Model
CURRENT DRUG TARGETS 16 2-12. .
-
De La Torre Ruiz MA
Unraveling oxidative stress. From yeast to human therapy.
CURRENT DRUG TARGETS 16 1-1. .
-
Milara J; Outeda-Macias M; Aumente-Rubio MD; Más-Serrano P; Aldaz A; Calvo MV; García-Simón MS; Martin-Barbero M; Padullés-Zamora N; Schoenenberger JA; Saavedra-Aldrich M; Tévar-Alfonso E; Saval A; Pastor-Clerigues A; García M; Margusino-Framiñan L; Montero-Alvarez JL; Merino E; Herrero JI; Beunza M; Conesa-Zamora P; Gimenez-Manzorro A; Comas-Sugrañes D; Cano-Marron M; Jiménez-Mutiloa E; Díaz-Ruíz P; Cortijo J
PEG-Interferon-a ribavirin-induced HCV viral clearance: a pharmacogenetic multicenter Spanish study.
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 39 29-43. .